Acurx Pharmaceuticals, Inc. · NASDAQ:ACXP

Acurx Pharmaceuticals, Inc. financial statements

Acurx Pharmaceuticals, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue0000000
Research and development1.83M5.40M6.04M4.75M2.03M2.20M3.51M
Selling, general and administrative6.26B8.70M8.53M7.34M208.3K2.40M2.42M
Operating income-8.09M-14.1M-14.6M-12.1M-12.9M-4.60M-5.93M
Depreciation and amortization14.1M14.6M12.1M66.5K4.60M5.93M
EBITDA0232224-12.8M00
Interest expense1.22K66.5K00
Income before tax-7.97M-14.1M-14.6M-12.1M-12.7M-4.60M-5.93M
Income tax-14.1B-14.6K0-66.5K0-5.93K
Net income-7.97M-14.1M-14.6M-12.1M-12.7M-4.60M-5.93M
Earnings per share, basic-5.32-17.45-1.15-1.12-1.49-0.74-12.43
Earnings per share, diluted-5.32-17.45-1.15-1.12-1.49-0.74

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash and equivalents7.56M3.71M7.47M9.11M13.0M3.18M2.48M
Receivables48.4K51.1K129.2K
Current assets7.69M3.86M7.71M9.38M13.3M3.22M2.53M
Total assets7.69M3.86M7.71M9.38M13.3M3.22M2.53M
Accounts payable3.81K29.5K63.4K2.30K
Current liabilities2.42M3.24M3.04M2.06M843.9K472.6K1.71M
Long-term debt49.9K
Total debt66.5K
Total liabilities2.42M3.24M3.04M2.06M843.9K522.4K1.71M
Shareholders' equity5.27M615.1K4.67M7.32M12.4M2.70M819.9K
Shares outstanding2.35M851.5K14.5M11.6M10.2M11.6M477.1K

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations-6.79M-10.4M-9.80M-7.54M-5.01M-3.35M-3.99M
Capital spending00-50-300
Free cash flow-6.79M-10.4M-9.80M-7.54M-5.01M-3.35M-3.99M
Cash from financing10.6M6.62M8.16M3.70M14.8M4.04M4.46M
Share buybacks-1.04K0
Change in cash3.85M-3.77M-1.64M-3.85M9.78M692.1K470.2K